Search Bar & Filters
Found 82 Actively Recruiting clinical trials
Actively Recruiting
This research aims to evaluate the additional effects of sternocleidomastoid muscle release combined with suboccipital muscle release in managing cervicogenic headache, a condition caused by dysfunction in the C1-C2 vertebrae and marked by neck stiffness and limited neck rotation. Cervicogenic headache significantly impacts daily activities and is associated with forward head posture and weak deep neck muscles. The study is a randomized control trial conducted by Foundation University Islamabad to explore these manual therapy techniques alongside conventional physical therapy treatments. Participants are divided into two groups. Group A will receive suboccipital muscle release consisting of three repetitions of three minutes each total 9 minutes, combined with conventional physical therapy including TENS and hot pack therapy for 10 minutes, six days a week for two consecutive weeks. Group B will receive sternocleidomastoid muscle release for 5 minutes plus the same suboccipital muscle release and conventional physical therapy schedule as group A. Both interventions are delivered over 12 sessions in total. During the study, participants will undergo assessments to measure pain intensity and range of motion after two weeks of treatment. Researchers will monitor headache symptoms, neck function, and muscle performance using clinical tests like the flexion rotation test. The study does not involve masking or blinding, and all participants will be adults aged 18 to 45 years. The total participation period includes the two-week treatment phase followed by outcome evaluations.
Actively Recruiting
Researchers are evaluating the effects of two different techniques, Facilitated Positional Release Technique FPRT and Manual Myofascial Release Technique, in female patients with Piriformis Syndrome. This randomized control trial aims to compare these treatments to see how they impact hip range of motion and pain levels in affected individuals. The study focuses on women aged 25 to 50 who have experienced Piriformis Syndrome symptoms for at least two months. Participants are divided into two groups a treatment group receiving the Facilitated Positional Release Technique and a control group receiving Manual Myofascial Release. The FPRT involves applying pressure over tender muscle areas while maintaining specific positions, with five repetitions. The control group undergoes 3 to 5 repetitions of manual myofascial release, applying ischemic pressure directly on the piriformis muscle for 90 seconds before release. At the start, baseline measurements of hip range of motion including abduction, adduction, internal and external rotation, pain levels using the Numeric Pain Rating Scale NPRS, and functional ability via the Lower Extremity Functional Scale LEFS are taken. After two weeks of treatment, these assessments are repeated to compare changes. The primary outcome measured is the change in range of motion after two weeks. The study is sponsored by Foundation University Islamabad and plans to conclude by April 2025.
Actively Recruiting
Researchers are conducting an international, multicenter, randomized, controlled, open-label Phase III trial to evaluate the effectiveness and safety of libevitug in people with chronic Hepatitis Delta Virus HDV infection. The study focuses on participants aged 12 to 70 years who have a history of chronic HDV infection and specific liver enzyme levels. Participants will be assigned to one of three groups one group receiving libevitug at 20 mgkg every two weeks through intravenous infusion for 96 weeks another group receiving a lower dose of 10 mgkg on the same schedule and a control group observed for 48 weeks before then receiving the 20 mgkg libevitug dosage for the following 48 weeks. This setup allows comparison of different dosing and delayed treatment effects. Throughout the study, participants will undergo regular evaluations including liver function tests, viral load measurements, and liver stiffness assessments. The primary outcome is the proportion of participants achieving a significant reduction in HDV RNA and normalization of liver enzymes at week 48. Additional outcomes will be monitored up to week 120, including safety monitoring for adverse events. The total participation may last up to about two and a half years, with careful follow-up to assess long-term effects.
Actively Recruiting
Researchers are evaluating the effects of adding dry needling to conventional physical therapy compared to conventional physical therapy alone on walking and pain in adults with plantar fasciitis. The study focuses on changes in pain, ankle range of motion, walking speed, stride, and daily activities in adults aged 40 to 60 years suffering from plantar heel pain lasting more than three months. This randomized controlled trial aims to provide insight into how these treatments influence gait and function. Participants receive either standard care including ultrasound, stretching, and strengthening exercises combined with sham dry needling, or the same standard care combined with real dry needling. Both groups undergo six treatment sessions over three weeks, twice per week. The dry needling targets specific foot and calf muscles with sterile needles applied for 5 minutes each session, while the sham group receives similar procedures without the active needle stimulation. During the study, participants will be assessed before and after treatment using pain rating scales, goniometer measurements for ankle motion, a 30-meter walk test, and the Foot and Ankle Ability Measure FAAM. Researchers will monitor pain intensity, gait speed, cadence, cycle length, stride length, and range of motion over three weeks. Consent will be obtained before participation, and data collection includes pre- and post-intervention scores to evaluate treatment effects.
Actively Recruiting
Researchers are evaluating the additional effects of Flutter therapy combined with conventional chest physiotherapy CPT on lung function and airway clearance in patients with mild-to-moderate chronic obstructive pulmonary disease COPD who have undergone elective coronary artery bypass grafting CABG. This randomized controlled trial includes 94 patients aged 40 to 70 years and aims to compare outcomes such as peak expiratory flow rate and chest expansion between two treatment groups during the early postoperative period. Participants are randomly assigned to one of two groups. The control group receives conventional chest physiotherapy, which includes deep breathing exercises, incentive spirometry, airway clearance techniques, splinted coughing, and early mobilization. The intervention group receives the same CPT combined with Flutter therapy using a portable oscillating positive expiratory pressure OPEP device. Both groups receive supervised treatment three times daily for five consecutive postoperative days, totaling 15 treatment sessions. Participants will undergo baseline assessments on the first postoperative day before starting treatment and post-treatment assessments on the fifth day. The study measures include peak expiratory flow rate, chest expansion, sputum volume, dyspnea, and breathlessness, cough, and sputum scale scores. The outcome assessor remains blinded to group assignments to reduce bias. Data will be collected systematically and analyzed to determine the additional role of Flutter therapy as an adjunct to CPT in this patient population.
Actively Recruiting
Researchers are evaluating the additional effects of combining mobilization with movement and upper quadrant core strengthening in people experiencing rotator cuff related shoulder pain. This randomized controlled trial aims to determine how these treatments impact pain, range of motion, proprioception, and fear of movement kinesiophobia. Participants are randomly assigned to one of two groups. One group performs an upper quadrant core strengthening protocol over four weeks, including scapular postural correction, shoulder shrugging, and rotation exercises. The other group performs the same strengthening protocol combined with mobilization techniques involving acromioclavicular, scapular, and glenohumeral joint glides. During the study, participants will have their pain intensity, shoulder range of motion, proprioception, and kinesiophobia measured after four weeks. Data collection includes assessments before and after treatment, and participants provide informed consent before enrollment. The study runs from July 2024 to June 2025.
Actively Recruiting
Researchers are investigating the effects of two muscle energy techniques, autogenic inhibition and reciprocal inhibition, on people with Iliotibial Band Syndrome, which causes lateral knee pain. This randomized, single-blinded trial aims to compare how these techniques influence pain, hip range of motion, and lower limb function over a two-week period. The study is conducted by Foundation University Islamabad and involves adults aged 19 to 45 years. Participants will be divided into two groups of 20 each. One group will receive the autogenic inhibition technique, which involves isometric contraction of the shortened muscle Tensor Fascia Latae followed by stretching. The other group will receive the reciprocal inhibition technique, which requires contracting the opposing muscles hip adductors before stretching the target muscle. Both groups will perform their respective exercises three times a week for two weeks. During the study, pain levels will be assessed using the Numeric Pain Rating Scale, hip range of motion measured with a goniometer, and lower extremity function evaluated by the Lower Extremity Functional Scale. These assessments will be conducted to monitor improvements in pain severity, mobility, and overall function after two weeks of treatment. Participants are closely monitored throughout the treatment period to evaluate these outcomes and ensure adherence to the exercise protocols.
Actively Recruiting
Acute lymphoblastic leukemia ALL is the most common cancer in children and the second most frequent acute leukemia in adults. B-cell ALL makes up about 85% of ALL cases. In Pakistan, ALL is the most common blood cancer treated at major centers. While initial chemotherapy can lead to remission in most children, relapse rates remain significant, and adults generally have poorer outcomes. For patients with relapsed or refractory disease, new treatment options are needed due to limitations of standard therapies and transplants. This study evaluates an investigational autologous anti-CD19 CAR-T cell therapy developed and manufactured on-site at AFBMTC in Pakistan. The treatment involves collecting a patients own T cells, modifying them to target CD19 on leukemia cells, and then infusing them after chemotherapy to reduce leukemia burden. The therapy uses a lentiviral vector and an automated bioreactor system to produce the CAR-T cells. This pilot trial aims to assess the safety, feasibility, and early effectiveness of this approach in patients aged 5 to 50 years with relapsed or refractory B-cell ALL. Participants will undergo leukapheresis to collect T cells, followed by CAR-T cell manufacturing and infusion after receiving lymphodepleting chemotherapy. Researchers will monitor participants for safety and treatment effects over one year after infusion. Assessments include blood tests, bone marrow evaluation, and performance status checks. Long-term follow-up for up to 15 years will track gene therapy safety. The study measures safety and feasibility as its primary outcomes and involves regular clinical visits and monitoring throughout the treatment and follow-up periods.
Actively Recruiting
Multiple myeloma is a cancer of plasma cells characterized by the production of abnormal monoclonal immunoglobulin proteins and displacement of normal bone marrow cells. This disease causes bone damage, anemia, infections, high calcium levels, kidney problems, and neurological issues. Despite advances in treatments like proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and stem cell transplants, multiple myeloma remains incurable and often relapses, highlighting the need for new therapies. This study is a phase 2 trial investigating a novel CAR-T cell therapy targeting BCMA in adults with relapsed or refractory multiple myeloma. The study involves collecting the patients own T cells, genetically modifying them to recognize BCMA on myeloma cells, then infusing these CAR-T cells back into the patient. This autologous BCMA-directed CAR-T cell therapy is given after screening and eligibility confirmation. The treatment aims to attack the cancer cells by enhancing the immune response. The trial is being conducted in Pakistan and focuses on patients who have had at least three prior treatment lines or are double refractory to key therapies. Participants will be screened for eligibility, provide informed consent, and undergo assessments including lab tests and disease measurements before treatment. After infusion, safety, tolerability, manufacturing feasibility, and delivery of the CAR-T product will be closely monitored for up to one year. The study also involves regular follow-ups and evaluations to assess participant health, organ function, and disease status throughout the trial period, which spans from enrollment to one year post-treatment.
Actively Recruiting
This research investigates the effects of closed chain versus open chain exercises combined with blood flow restriction on pain, range of motion, strength, and functional performance in adults aged 45 to 75 with mild to moderate knee osteoarthritis. The study is a randomized controlled trial conducted at two medical centers with 40 participants divided equally between the two exercise groups. The trial aims to better understand which exercise approach may impact knee osteoarthritis symptoms and function. Participants receive either closed kinetic chain or open kinetic chain quadriceps strengthening exercises under blood flow restriction, alongside conservative therapy including hot packs, TENS, and Mulligan mobilization. Exercises follow a standardized low-load protocol with 4 sets of 30, 15, 15, and 15 repetitions performed three times weekly over four weeks, totaling 12 sessions. Each session lasts about 40 minutes and includes conventional physiotherapy elements. During the study, participants are assessed before and after the 4-week intervention using tools such as the Numeric Pain Rating Scale, Western Ontario and McMaster Universities Osteoarthritis Index WOMAC, goniometer measurements for knee flexion and extension, a dynamometer for muscle strength, and a 30-second chair stand test. Data analysis evaluates changes in pain, function, and strength. The study provides close monitoring throughout the 4-week treatment period to measure outcomes and safety.
1-10 of 82
1